BeiGene Ltd ADR’s recent filing unveils that its Global Head of R&D Wang Lai unloaded Company’s shares for reported $1.29 million on Feb 21 ’25. In the deal valued at $257.23 per share,5,000 shares were sold. As a result of this transaction, Wang Lai now holds 0 shares worth roughly $0.0.
Then, Lee Chan Henry sold 1,202 shares, generating $310,170 in total proceeds. Upon selling the shares at $258.04, the SVP, General Counsel now owns 0 shares.
Before that, CHAN LEE bought 1,202 shares. BeiGene Ltd ADR shares valued at $293,528 were divested by the Officer at a price of $244.20 per share.
A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in mid September with a ‘”a Mkt outperform”‘ rating. Macquarie started covering the stock on September 12, 2023. It rated ONC as “an Outperform”.
Price Performance Review of ONC
On Tuesday, BeiGene Ltd ADR [NASDAQ:ONC] saw its stock jump 0.47% to $259.70. Over the last five days, the stock has gained 9.07%. BeiGene Ltd ADR shares have risen nearly 40.60% since the year began. Nevertheless, the stocks have risen 68.88% over the past one year. While a 52-week high of $260.98 was reached on 02/25/25, a 52-week low of $126.97 was recorded on 01/08/25. SMA at 50 days reached $207.08, while 200 days put it at $190.66.
Levels Of Support And Resistance For ONC Stock
The 24-hour chart illustrates a support level at 256.69, which if violated will result in even more drops to 253.68. On the upside, there is a resistance level at 264.30. A further resistance level may holdings at 268.90. The Relative Strength Index (RSI) on the 14-day chart is 82.27, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 22.63, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.06%. Stochastics %K at 89.46% indicates the stock is a selling.
The most recent change occurred on August 17, 2023 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $287 price target.
